Translation News and Research

RSS

Modified protein plays a key role in memory processes

How do we process thoughts and store memories? A team of researchers headed by Dr. Nahum Sonenberg of McGill's Department of Biochemistry and Goodman Cancer Centre has discovered that brains in mammals modify a particular protein in a unique way, which alters the protein's normal function.

26 Mar 2010

New research may help advance treatment strategies for common liver disease

A research article published in the journal PloS Pathogens could lead to improvements in the production of vaccines for hepatitis A, the most widespread viral disease in the world.

26 Mar 2010

ASCO, ESMO and OECI endorse WIN Symposium's initiatives on improving outcomes of cancer

The WIN Consortium, supported by its media partner Nature Publishing Group, has opened registration for the second annual WIN Symposium, to be held in the Palais des Congrès, Paris, on the 7th to 9th of July 2010. The WIN Symposium is an open and interactive forum designed to promote rapid translation of ground-breaking personalized cancer medicine discoveries to clinical practice.

25 Mar 2010

Bone stem cells could become a part of new, innovative hip replacement treatment

Bone stem cells could in future be used instead of bone from donors as part of an innovative new hip replacement treatment, according to scientists at the University of Southampton.

24 Mar 2010

China Biologic Products' fourth quarter revenue rises 185.6%

China Biologic Products, Inc., one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, operating through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd and Guiyang Dalin Biologic Technologies Co., Ltd. and its equity investment in Xi'an Huitian Blood Products Co., Ltd., today reported financial results for the fourth quarter and year ended December 31, 2009.

24 Mar 2010

GUMC scientists awarded five-year $7.5M grant to perfect treatment of breast cancer

Scientists at the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center were awarded a five-year $7.5 million grant to tease apart - in the most comprehensive way ever devised -the role of a single protein receptor in breast cells in cancer development and treatment.

22 Mar 2010

CRT, Cephalon to collaborate on development of small molecule inhibitors against cancer

Cancer Research Technology has announced an exclusive agreement with Cephalon, Inc., an international biotechnology company, to collaborate on the development of small molecule inhibitors. These molecules will target specific members of the 'protein kinase C' superfamily of cell signalling proteins - which have been shown to be associated with the development of cancer.

22 Mar 2010

Medical Facilities' service revenue increases from $199.4M in 2008 to $207.4M in 2009

Medical Facilities Corporation, today reported its financial results for the three and twelve-month periods ended December 31, 2009. All amounts are expressed in U.S. dollars unless indicated otherwise.

22 Mar 2010

‘Young Minds’ program for graduate and post-doctoral students

The Regenerative Medicine Foundation is pleased to announce a special "Young Minds" graduate student registration rate for its annual Translational Regenerative Medicine Forum, set for April 6-8 in Winston-Salem.

20 Mar 2010

Turning microRNAs into novel drugs

Researchers around the globe are working on turning microRNAs, over 5,000 of which already have been identified, into novel drugs for a wide range of applications, reports Genetic Engineering & Biotechnology News (GEN). These noncoding single-stranded RNAs act through binding to complementary mRNA sequences, thus preventing their translation into protein or accelerating mRNA breakdown, according to the March 15 issue of GEN.

20 Mar 2010

Robertson Foundation commits $10.2M for Duke Medicine's cell therapy research

A $10.2 million commitment from the Robertson Foundation to create a state-of-the-art Translational Cell Therapy Center (TCTC) will advance Duke Medicine's pioneering cell therapy research and treatment programs for children and adults with cancer, cerebral palsy, stroke and brain injuries suffered at birth.

19 Mar 2010

Bench to Bassinet Program aims to move lab results into clinical practice

To help speed the translation of scientific discoveries into usable treatments in congenital heart disease, the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health launched the Bench to Bassinet Program.

17 Mar 2010

Keynote speakers to discuss regenerative medicine therapies at upcoming forum

What regenerative medicine therapies are being applied to patients today? What hurdles stand between stem cell therapies and real treatments in the clinic? Keynote speakers at the upcoming inaugural Translational Regenerative Medicine Forum will discuss these topics as well as provide an update on various national and regional stem cell initiatives.

16 Mar 2010

Study suggests HuR gene plays a critical role in inducing cells' inflammatory response

To understand the role of inflammation in cardiovascular and other diseases, it is essential to identify and characterize genes that induce an inflammatory response in the body -- and the genes that regulate them.

16 Mar 2010

Healthways, Blue Zones establish Healthways-Blue Zones Vitality Quest to improve community well-being

Today, Healthways, Inc. and Blue Zones, LLC, announced the establishment of Healthways-Blue Zones Vitality QuestSM, an exclusive, strategic relationship to create, support and sustain a national movement to improve community health and well-being, initially for cities in the U.S.

15 Mar 2010

One-day C.A.R.E. clinic at Georgia International Convention Center looking for medical volunteers

Volunteers are urgently needed for a one-day, free health clinic in the Atlanta area this month that is expected to serve more than 1,000 uninsured Georgia residents.

12 Mar 2010

Tyco International declares quarterly dividend of CHF 0.22 per share

The Board of Directors of Tyco International Ltd. today declared a quarterly dividend of 0.22 Swiss Francs (CHF) per share, payable on May 26, 2010 to shareholders of record at the close of business on April 30, 2010, subject to a required filing with the Swiss Commercial Register.

11 Mar 2010

Few CE studies compare medications with nonpharmacologic interventions, and examine safety or cost-effectiveness

An analysis of comparative effectiveness studies finds that few compare medications with nonpharmacologic interventions, and few examine safety or cost-effectiveness, according to a study in the March 10 issue of JAMA.

10 Mar 2010

Helix BioPharma reports 29.9% increase in total revenues for second-quarter fiscal 2010

Helix BioPharma Corp. today announced financial results for the second quarter ended January 31, 2010.

10 Mar 2010

Corporate Translations switches to Across Language Server for translation management software

Corporate Translations, Inc., a leading translation service provider specializing in the life science industry, has recently switched from Trados to the Across Language Server for its translation management software. The company indicates that the Across technology better meets its core values of speed, accuracy, flexibility and innovation; Corporate Translations will move all of its suitable translation projects to the Across Language Server over the course of 2010.

10 Mar 2010

Translation News and Research

Modified protein plays a key role in memory processes

New research may help advance treatment strategies for common liver disease

ASCO, ESMO and OECI endorse WIN Symposium's initiatives on improving outcomes of cancer

Bone stem cells could become a part of new, innovative hip replacement treatment

China Biologic Products' fourth quarter revenue rises 185.6%

GUMC scientists awarded five-year $7.5M grant to perfect treatment of breast cancer

CRT, Cephalon to collaborate on development of small molecule inhibitors against cancer

Medical Facilities' service revenue increases from $199.4M in 2008 to $207.4M in 2009

‘Young Minds’ program for graduate and post-doctoral students

Turning microRNAs into novel drugs

Robertson Foundation commits $10.2M for Duke Medicine's cell therapy research

Bench to Bassinet Program aims to move lab results into clinical practice

Keynote speakers to discuss regenerative medicine therapies at upcoming forum

Study suggests HuR gene plays a critical role in inducing cells' inflammatory response

Healthways, Blue Zones establish Healthways-Blue Zones Vitality Quest to improve community well-being

One-day C.A.R.E. clinic at Georgia International Convention Center looking for medical volunteers

Tyco International declares quarterly dividend of CHF 0.22 per share

Few CE studies compare medications with nonpharmacologic interventions, and examine safety or cost-effectiveness

Helix BioPharma reports 29.9% increase in total revenues for second-quarter fiscal 2010

Corporate Translations switches to Across Language Server for translation management software

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News